Mizuho keeps Belite Bio at outperform; raises target to $234
Mizuho maintained Belite Bio at outperform and raised its price target to $234.00 per share from $220.00, according to Benzinga via TradingView News.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Mizuho maintained Belite Bio at outperform and raised its price target to $234.00 per share from $220.00, according to Benzinga via TradingView News.
HC Wainwright & Co. raised its price target for Belite Bio to $245.00 per share from $214.00, according to Benzinga (via TradingView News).
H.C. Wainwright raises BLTE price target to $214 from $200